- 09 apr.- 09:13

Relief Therapeutics (RLF:SIX) Drug Aviptadil Enters FDA Trial at Thomas Jefferson University Hospital in Philadelphia, to Treat COVID-19-induced Acute Respiratory Distress

Business Wire.

Aviptadil targets the cytokine storm that causes fatal Respiratory Distress in COVID-19

  • Coronavirus (COVID-19) death is primarily caused by Acute Respiratory Distress Syndrome (ARDS), in which severe inflammation causes the lungs to fill with fluid and even mechanical ventilation is unable to maintain life. The syndrome is caused, in part, by a Cytokine Storm unleashed by viral particles.
  • VIP is known to have potent anti-cytokine effects in numerous animal models and in phase 1 and phase 2 human studies
- 08 apr.- 14:03

IDEMIA, ZWIPE e IDEX centrano un risultato storico per il lancio di avanzate piattaforme per carte di pagamento biometriche

Business Wire.
  • IDEMIA, leader globale dell'identità aumentata, e l'importante fintech biometrica ZWIPE, nell'ambito di un programma prestabilito1, oggi hanno annunciato l'arrivo dei primi prototipi dell'elemento per la sicurezza biometrica di prossima generazione.
  • Questo dispositivo costituirà il nucleo dell'avanzata card biometrica F.CODE che IDEMIA fornirà alle istituzioni finanziarie.
  • ZWIPE, il detentore dei diritti esclusivi e mondiali di distribuzione per questa tecnologia, consentirà ai propri clienti di usufruire della nuova piattaforma in anteprima2.
  • IDEMIA ha scelto IDEX Biometrics, leader nelle soluzioni avanzate di identificazione e autenticazione basate sulle impronte digitali, come fornitore del sensore biometrico per la nuova piattaforma.
  • Le tre aziende procederanno a un primo lancio nel secondo semestre del 2020, con l'immissione sul mercato prevista a partire dal 2021.
- 08 apr.- 14:00

XPRIZE Taps Visionary Sci-Fi Writers to Imagine the Future of Telepresence Technologies

Business Wire.

James SA Corey, Adrian Tchaikovsky, Tade Thompson, JY Yang, Charles Yu, Johanna Sinisalo are among the writers contributing to the new online anthology presented as a collection of avatar ‘memories’ spanning the 21st century

The public is asked to find and submit the ‘missing’ avatar memory via a short story contest

- 08 apr.- 09:00

IDEMIA, ZWIPE and IDEX Achieve Key Milestone Towards Next Generation Biometric Card Platform

Business Wire.
  • IDEMIA, the global leader in Augmented Identity, and ZWIPE, a leading biometric fintech company, announce today, as per plan1, the arrival of the first engineering samples of the next generation of the biometric secure element.
  • This device will be the heart of the F.CODE next generation biometric card that IDEMIA will sell to Financial Institutions.
  • ZWIPE, the holder of worldwide and exclusive rights to distribute this technology, will benefit from early availability of this new platform for their customers2.
  • IDEMIA has selected IDEX Biometrics, a leading provider of advanced fingerprint identification and authentication solutions, as the supplier of the biometric sensor for the new platform.
  • The three companies will be piloting in the second half of 2020, with commercial rollout planned from 2021 and onwards.
- 08 apr.- 08:00

COVID-19: Boehringer Ingelheim steps up effort with Global Support Program

Business Wire.
  • Global support fund for local relief increased to EUR 5.8 million
  • Over 100 scientists and 11,000 lab hours committed to COVID-19 research in international consortia, expected to expand
  • 10 days paid leave offered to 51,000 employees for volunteering
  • EUR 580,000 relief fund made available for Making More Health communities and social entrepreneurs in India and Kenya

Video Economia

Vai alla rubrica Risparmio e Investimenti
Vai al sito: ANSA Professioni


Vai al sito: L'Agenda Economica Finanziaria e Rassegna Stampa dell'ANSA
Vai alla rubrica: Pianeta Camere
Vai alla rubrica: Agrimercati
Vai alla rubrica: PMI

Real Estate

Criptovalute news


Modifica consenso Cookie